Navidea Biopharmaceuticals Announces Dual Listing on Tel Aviv Stock Exchange

By: via Benzinga
Navidea Biopharmaceuticals Inc., (NYSE MKT: NAVB), a biopharmaceutical company focused on the development and commercialization of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.